AO
Akgul, Ozgur
10 papers · 26 citations · 2021–2026
Publications
10
Citations
26
Years
6
Publications
| Title | Year | Type | Citations |
|---|---|---|---|
|
Epidemiology and histopathological spectrum of appendiceal pathologies in 40.286 adults: a multicenter study from Turkey (2017-2025)
|
2026 | Article | 0 |
|
Prevalence and risk factors of difficult-to-treat axial spondyloarthritis: Real-life evidence from the BioSTaR database
|
2026 | Article | 0 |
|
Gender-related Differences in Peripheral and Axial Spondyloarthritis
|
2025 | Meeting Abstract | 0 |
|
Clinical characteristics of peripheral joint disease in axial and peripheral spondyloarthritis: findings from a multicentre cross-sectional study
|
2025 | Article | 1 |
|
The impact of obesity and overweight on rheumatoid arthritis patients: real-world insights from a biologic and targeted synthetic DMARDs registry
|
2025 | Article | 2 |
|
Pandemic of the century: COVID-19 in inflammatory rheumatic diseases of a national cohort with 3,532 patients
|
2024 | Article | 2 |
|
Real-life data on the comorbidities in spondyloarthritis from our multicenter nationwide registry: BioStar
|
2023 | Article | 10 |
|
Demographic and Clinical Characteristics of Patients with Sustained and Switching Treatments Using Biological and Targeted Synthetic Disease-Modifying Antirheumatic Drugs: A Multicenter, Observational Cross-Sectional Study for Rheumatoid Arthritis
|
2022 | Article | 3 |
|
Where we are in treat to target era? Predictive factors for remission and drug switching in patients with axial spondyloarthritis: a real-life evidence from BioStaR nationwide registry
|
2022 | Article | 3 |
|
Clinical performance of rheumatoid arthritis impact of disease score: a real-life evidence from the multicenter nationwide registry BioStaR
|
2021 | Article | 5 |